FDA seeking patient input on bleeding disorders

FDA is holding a public meeting on Sept. 22 to obtain patient input on the effects and current treatment approaches for hemophilia A, hemophilia B, von Willebrand disease and other heritable bleeding disorders. The agency is seeking input on the effects of the disorders, including which symptoms have the most significant impact on daily life, as well as input on how well current treatments work and the most significant disadvantages or complications. The agency is also seeking patient input on clinical trials for treatments, including factors that affect whether they will enroll in trials. ...